| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Iterum Therapeutics Plc (ITRM) has 2 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. ITRM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 241.0K | $7.2K | - | |
| Other | 200.0K | $6.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 30, 2018 | Chin Mark | Director | Buy | 58,000 | $6.10 | $353,800.00 | +5.6% | |
| Sep 4, 2018 | Dunne Michael W. | Chief Scientific Officer | Buy | 500 | $10.00 | $5,000.00 | +0.3% | |
| Aug 27, 2018 | Dunne Michael W. | Chief Scientific Officer | Buy | 1,000 | $10.00 | $10,000.00 | +0.3% | |
| Aug 23, 2018 | Edick Paul R | Director | Buy | 500 | $10.44 | $5,218.70 | +2.0% | |
| Aug 17, 2018 | Fishman Corey N. | President &CEO | Buy | 2,000 | $8.73 | $17,465.60 | +0.8% | |
| May 30, 2018 | Sofinnova Venture Partners Ix, L.P. | 10% Owner | Buy | 500,000 | $13.00 | $6,500,000.00 | +40.8% | |
| May 30, 2018 | Healy James | Director, 10% Owner | Buy | 500,000 | $13.00 | $6,500,000.00 | +40.8% | |
| May 30, 2018 | Matthews Judith M. | Chief Financial Officer | Buy | 4,000 | $13.00 | $52,000.00 | +7.7% | |
| May 30, 2018 | Heron Patrick J86 | Director, 10% Owner | Buy | 456,099 | $13.00 | $5,929,287.00 | +42.1% | |
| May 30, 2018 | Canaan X L.P. | Director, 10% Owner | Buy | 506,656 | $13.00 | $6,586,528.00 | +41.3% |